top of page

Cellicure, Inc

Founded Year:

2021

Stage:

Pre-A to Series A

Website:

Cellicure provides innovative cell-based immunotherapy technologies, customized treatment regimens and real-world solutions for the current unmet therapeutic needs created by cancer, infectious diseases, and chronic inflammatory diseases. The company has a rich pipeline of products and has established cutting-edge R&D centers, along with GMP manufacturing facilities.

Subscribe to our news letter. Don't miss out!

Thanks for subscribing!

©2022 H7 BioCapital

All rights reserved.

bottom of page